The Europe tumor ablation market size was valued at USD 0.34 Billion in 2025, driven by the rising preference for minimally invasive treatment procedures in the region. The market is expected to grow at a CAGR of 12.92% during the forecast period of 2026-2035, with the values likely to reach USD 1.15 Billion by 2035.
Base Year
Historical Period
Forecast Period
In December 2023, Clinical Laserthermia Systems (CLS) participated in IRMPROFT (a research study) with its TRANBERG system, a cutting-edge solution for minimally invasive, image-guided focal laser ablation aimed at treating cancer. The application of tumor ablation with combination therapies is projected to increase the Europe tumor ablation market growth in the forecast period.
The market is affected by the rising number of FDA approvals for new tumor ablation systems, including Medtronic receiving a 510(k) clearance for OsteoCool™ 2.0, their new tumor ablation system.
Cancer is the fourth most common cause of death in Europe, causing the tumor ablation market to keep expanding with innovations and technological advancements.
Compound Annual Growth Rate
12.92%
Value in USD Billion
2026-2035
*this image is indicative*
Tumor ablation is a minimally invasive procedure that uses extreme heat or cold to shrink or destroy tumors. It involves inserting a needle-tipped catheter into the tumor with the help of imaging guidance. The technological advancements along with the innovation of new procedures are expected to generate profitable opportunities, thereby, contributing to increased Europe tumor ablation market share.
The rising geriatric population and growing prevalence of cancer cases are amongst some of the most influential factors responsible for driving the growth of the market. After cardiovascular diseases, cancer is the most common cause of death and morbidity in Europe accounting for more than 3.7 million new cases and 1.9 million deaths each year in Europe. The market is also experiencing significant traction due to the rising demand for minimally invasive treatments and increasing awareness about ablation procedures, propelling the heightening of the Europe tumor ablation market demand.
In March 2024, Medtronic plc received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool™ 2.0 bone tumor ablation system for the treatment of painful bone metastases and benign bone tumors such as osteoid osteoma. Integrated with several new features OsteoCool is poised to bring innovation to the market. Portfolio expansions by market players are expected to influence the Europe tumor ablation market size in the coming years.
The market is further influenced by the increasing number of research activities, and efforts of key players towards expanding their global footprint as well as enhance the existing technologies present in the market. In December 2023, Clinical Laserthermia Systems (CLS) announced participation in a new research study, called IRMPROFT, to examine the use of MRI in combination with biopsies to diagnose residual prostate cancer post-focal therapy. The company is participating in this study with their TRANBERG system, a cutting-edge solution for minimally invasive, image-guided focal laser ablation aimed at treating cancer. The application of tumor ablation in combination with other therapies is poised to drive market growth in the forecast period.
The report offers a detailed analysis of the market based on the following segments:
Breakup by Technology
Breakup by Application
Breakup by Mode of Treatment
Breakup by End User
Breakup by Region
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Upto 15% Off
USD
$2699 $2429
$4299 $3869
$5799 $4949
$6999 $5949
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 0.34 Billion in 2025 driven by the rising geriatric population in the region.
The market is anticipated to grow at a CAGR of 12.92% during the forecast period of 2026-2035, likely to reach a market value of USD 1.15 Billion by 2035.
Factors contributing to the market demand include the rising geriatric population and the prevalence of cancer in the region.
One of the significant trends in the market is the increasing technological advancement in the ablation processes like microwave ablation, and cryoablation among others.
By technology, the market is segmented into radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and other ablation technologies.
It finds wide applications in kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and bone cancer.
By treatment, the market is segmented into surgical ablation, laparoscopic ablation, and percutaneous ablation.
End users of the market are hospitals, cancer specialty clinics, and others.
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy.
The key players in the market are EDAP TMS, Mermaid Medical, BVM Medical Limited, Cortex Technology, Olympus Corporation, BIOTRONIK SE & Co KG, Boston Scientific Corporation, AngioDynamics, Inc., Merit Medical Systems, Inc., and Medtronic plc.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by Mode of Treatment |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share